NEW YORK (Reuters Health) - Testing for genetic defects early in pregnancy through chorionic villus sampling, or CVS, does not appear to raise the risk of fetal loss. CVS involves using a needle to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback